These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33989086)

  • 1. Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM).
    Rosli MR; Wu DB; Neoh CF; Karuppannan M
    J Med Econ; 2021; 24(1):730-740. PubMed ID: 33989086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: a randomised controlled trial.
    Rosli MR; Neoh CF; Wu DB; Hassan NW; Mahmud M; Rahimi A; Karuppannan M
    Pharm Pract (Granada); 2021; 19(3):2397. PubMed ID: 34621450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa.
    Huang SJ; Galárraga O; Smith KA; Fuimaono S; McGarvey ST
    Hum Resour Health; 2019 Mar; 17(1):17. PubMed ID: 30836964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective.
    Charokopou M; McEwan P; Lister S; Callan L; Bergenheim K; Tolley K; Postema R; Townsend R; Roudaut M
    BMC Health Serv Res; 2015 Nov; 15():496. PubMed ID: 26541516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home-based medication review in older people: is it cost effective?
    Pacini M; Smith RD; Wilson EC; Holland R
    Pharmacoeconomics; 2007; 25(2):171-80. PubMed ID: 17249858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes.
    Guzauskas GF; Rind DM; Fazioli K; Chapman RH; Pearson SD; Hansen RN
    J Manag Care Spec Pharm; 2021 Apr; 27(4):455-468. PubMed ID: 33769850
    [No Abstract]   [Full Text] [Related]  

  • 7. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost utility analysis alongside a cluster-randomised trial evaluating a minor ailment service compared to usual care in community pharmacy.
    Amador-Fernández N; Benrimoj SI; García-Mochón L; García-Cárdenas V; Dineen-Griffin S; Gastelurrutia MÁ; Gómez-Martínez JC; Colomer-Molina V; Martínez-Martínez F
    BMC Health Serv Res; 2021 Nov; 21(1):1253. PubMed ID: 34798895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.
    Gourzoulidis G; Tzanetakos C; Ioannidis I; Tsapas A; Kourlaba G; Papageorgiou G; Maniadakis N
    Clin Drug Investig; 2018 May; 38(5):417-426. PubMed ID: 29349708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses.
    McGlone ER; Carey I; Veličković V; Chana P; Mahawar K; Batterham RL; Hopkins J; Walton P; Kinsman R; Byrne J; Somers S; Kerrigan D; Menon V; Borg C; Ahmed A; Sgromo B; Cheruvu C; Bano G; Leonard C; Thom H; le Roux CW; Reddy M; Welbourn R; Small P; Khan OA
    PLoS Med; 2020 Dec; 17(12):e1003228. PubMed ID: 33285553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece.
    Gourzoulidis G; Tzanetakos C; Ioannidis I; Tsimihodimos V; Diogo V; Karpouzos G; Papageorgiou G; Kourlaba G
    Clin Drug Investig; 2021 Apr; 41(4):371-380. PubMed ID: 33687695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial).
    Panca M; Christie D; Cole TJ; Costa S; Gregson J; Holt R; Hudson LD; Kessel AS; Kinra S; Mathiot A; Nazareth I; Wataranan J; Wong ICK; Viner RM; Morris S
    BMJ Open; 2018 Feb; 8(2):e018640. PubMed ID: 29449292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
    Leal J; Ahrabian D; Davies MJ; Gray LJ; Khunti K; Yates T; Gray AM
    BMJ Open; 2017 Jan; 7(1):e013592. PubMed ID: 28069625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of a community paramedicine programme for low-income seniors living in subsidised housing: the community paramedicine at clinic programme (CP@clinic).
    Agarwal G; Pirrie M; Angeles R; Marzanek F; Thabane L; O'Reilly D
    BMJ Open; 2020 Oct; 10(10):e037386. PubMed ID: 33109643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
    Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D;
    BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of multicomponent interventions in type 2 diabetes mellitus in a cluster randomised controlled trial: the INDICA study.
    García-Pérez L; Ramallo-Fariña Y; Vallejo-Torres L; Rodríguez-Rodríguez L; González-Pacheco H; Santos-Hernández B; García-Bello MA; Wägner AM; Carmona M; Serrano-Aguilar PG;
    BMJ Open; 2022 Apr; 12(4):e058049. PubMed ID: 35396305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.